中华老年多器官疾病杂志
中華老年多器官疾病雜誌
중화노년다기관질병잡지
CHINESE JOURNAL OF MULTIPLE ORGAN DISEASES IN THE ELDERLY
2015年
8期
620-623
,共4页
老年人%脑动脉硬化%阿托伐他汀钙%临床效果
老年人%腦動脈硬化%阿託伐他汀鈣%臨床效果
노년인%뇌동맥경화%아탁벌타정개%림상효과
aged%cerebral arteriosclerosis%atorvastatin calcium%clinical efficiency
目的:探讨阿托伐他汀钙治疗老年脑动脉硬化的临床效果。方法选取于2012年12月至2014年12月期间入住海南医学院附属医院的124例老年脑动脉硬化患者进行分析。随机将其分为试验组和对照组(各62例),对照组采用常规方法进行治疗,试验组在对照组的基础上加用阿托伐他汀钙进行治疗;治疗6个月后,观察两组患者的血脂水平、颅内动脉弹性指标、颈动脉硬化斑块大小及脑血管疾病的发生情况等。结果两组患者治疗后的血脂水平、颅内动脉弹性指标、颈动脉硬化斑块大小均较治疗前有所改善,差异具有统计学意义(P<0.05);治疗后试验组的血脂水平、颅内动脉弹性指标、颈动脉硬化斑块大小明显优于对照组,差异具有统计学意义(P<0.05)。试验组的总有效率(98.4%)明显高于对照组(80.6%),差异具有统计学意义(χ2=5.436,P<0.05);试验组的脑血管疾病发生率(3.2%)明显低于对照组(16.1%),差异具有统计学意义(χ2=5.324,P<0.05)。结论老年脑动脉硬化患者采用阿托伐他汀钙治疗可明显改善患者的症状,对减少脑血管疾病的发生具有重要的临床意义。
目的:探討阿託伐他汀鈣治療老年腦動脈硬化的臨床效果。方法選取于2012年12月至2014年12月期間入住海南醫學院附屬醫院的124例老年腦動脈硬化患者進行分析。隨機將其分為試驗組和對照組(各62例),對照組採用常規方法進行治療,試驗組在對照組的基礎上加用阿託伐他汀鈣進行治療;治療6箇月後,觀察兩組患者的血脂水平、顱內動脈彈性指標、頸動脈硬化斑塊大小及腦血管疾病的髮生情況等。結果兩組患者治療後的血脂水平、顱內動脈彈性指標、頸動脈硬化斑塊大小均較治療前有所改善,差異具有統計學意義(P<0.05);治療後試驗組的血脂水平、顱內動脈彈性指標、頸動脈硬化斑塊大小明顯優于對照組,差異具有統計學意義(P<0.05)。試驗組的總有效率(98.4%)明顯高于對照組(80.6%),差異具有統計學意義(χ2=5.436,P<0.05);試驗組的腦血管疾病髮生率(3.2%)明顯低于對照組(16.1%),差異具有統計學意義(χ2=5.324,P<0.05)。結論老年腦動脈硬化患者採用阿託伐他汀鈣治療可明顯改善患者的癥狀,對減少腦血管疾病的髮生具有重要的臨床意義。
목적:탐토아탁벌타정개치료노년뇌동맥경화적림상효과。방법선취우2012년12월지2014년12월기간입주해남의학원부속의원적124례노년뇌동맥경화환자진행분석。수궤장기분위시험조화대조조(각62례),대조조채용상규방법진행치료,시험조재대조조적기출상가용아탁벌타정개진행치료;치료6개월후,관찰량조환자적혈지수평、로내동맥탄성지표、경동맥경화반괴대소급뇌혈관질병적발생정황등。결과량조환자치료후적혈지수평、로내동맥탄성지표、경동맥경화반괴대소균교치료전유소개선,차이구유통계학의의(P<0.05);치료후시험조적혈지수평、로내동맥탄성지표、경동맥경화반괴대소명현우우대조조,차이구유통계학의의(P<0.05)。시험조적총유효솔(98.4%)명현고우대조조(80.6%),차이구유통계학의의(χ2=5.436,P<0.05);시험조적뇌혈관질병발생솔(3.2%)명현저우대조조(16.1%),차이구유통계학의의(χ2=5.324,P<0.05)。결론노년뇌동맥경화환자채용아탁벌타정개치료가명현개선환자적증상,대감소뇌혈관질병적발생구유중요적림상의의。
ObjectiveTo evaluate the clinical efficiency of atorvastatin calcium in the treatment of senile cerebral arteriosclerosis. Methods A total of 124 elderly patients with cerebral arteriosclerosis admitted in our hospital from December 2012 to December 2014 were subjected in this study. They were randomly divided into test group and control group (n=62). The control group was given conventional treatment, and the test group was administered by atorvastatin calcium besides of conventional treatment for 6 months. Blood lipids, intracranial artery elasticity index, size of carotid artery plaque and incidence of cerebrovascular diseases were measured and compared between the 2 groups.Results The blood lipids, intracranial artery elasticity index, and size of cerebral artery plaque were obviously improved in the 2 groups after treatment when compared with before the treatment (P<0.05), and those in the test group were more significant than in the control group (P<0.05). The total effective rate was 98.4% in the test group, remarkably higher than that of the control group (80.6%,χ2=5.436,P<0.05). The incidence of cerebrovascular disease was markedly lower in the test group than in the control group (3.2%vs 16.1%,χ2=5.324,P<0.05).Conclusion Atorvastatin calcium effectively attenuates the symptoms in the elderly patients with cerebral arteriosclerosis, and reduces the occurrences of cerebrovascular diseases.